Literature DB >> 10722740

The amyloid precursor protein-binding protein APP-BP1 drives the cell cycle through the S-M checkpoint and causes apoptosis in neurons.

Y Chen1, D L McPhie, J Hirschberg, R L Neve.   

Abstract

APP-BP1 binds to the amyloid precursor protein (APP) carboxyl-terminal domain. Recent work suggests that APP-BP1 participates in a novel ubiquitinylation-related pathway involving the ubiquitin-like molecule NEDD8. We show here that, in vivo in mammalian cells, APP-BP1 interacts with hUba3, its presumptive partner in the NEDD8 activation pathway, and that the APP-BP1 binding site for hUba3 is within amino acids 443-479. We also provide evidence that the human APP-BP1 molecule can rescue the ts41 mutation in Chinese hamster cells. This mutation previously has been shown to lead to successive S phases of the cell cycle without intervening G(2), M, and G(1), suggesting that the product of this gene negatively regulates entry into the S phase and positively regulates entry into mitosis. We show that expression of APP-BP1 in ts41 cells drives the cell cycle through the S-M checkpoint and that this function requires both hUba3 and hUbc12. Overexpression of APP-BP1 in primary neurons causes apoptosis via the same pathway. A specific caspase-6 inhibitor blocks this apoptosis. These findings are discussed in the context of abnormalities in the cell cycle that have been observed in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10722740     DOI: 10.1074/jbc.275.12.8929

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  Covalent modifier NEDD8 is essential for SCF ubiquitin-ligase in fission yeast.

Authors:  F Osaka; M Saeki; S Katayama; N Aida; A Toh-E; K Kominami; T Toda; T Suzuki; T Chiba; K Tanaka; S Kato
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

2.  Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a Cullin-containing complex.

Authors:  E Querido; P Blanchette; Q Yan; T Kamura; M Morrison; D Boivin; W G Kaelin; R C Conaway; J W Conaway; P E Branton
Journal:  Genes Dev       Date:  2001-12-01       Impact factor: 11.361

3.  NEDD8 recruits E2-ubiquitin to SCF E3 ligase.

Authors:  T Kawakami; T Chiba; T Suzuki; K Iwai; K Yamanaka; N Minato; H Suzuki; N Shimbara; Y Hidaka; F Osaka; M Omata; K Tanaka
Journal:  EMBO J       Date:  2001-08-01       Impact factor: 11.598

Review 4.  Dysfunction of amyloid precursor protein signaling in neurons leads to DNA synthesis and apoptosis.

Authors:  Rachael L Neve; Donna L McPhie
Journal:  Biochim Biophys Acta       Date:  2006-10-18

Review 5.  Divide and die: cell cycle events as triggers of nerve cell death.

Authors:  Karl Herrup; Rachael Neve; Susan L Ackerman; Agata Copani
Journal:  J Neurosci       Date:  2004-10-20       Impact factor: 6.167

6.  CAND1-mediated substrate adaptor recycling is required for efficient repression of Nrf2 by Keap1.

Authors:  Shih-Ching Lo; Mark Hannink
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

Review 7.  E3 ubiquitin ligases in protein quality control mechanism.

Authors:  Deepak Chhangani; Ajay Prakash Joshi; Amit Mishra
Journal:  Mol Neurobiol       Date:  2012-05-19       Impact factor: 5.590

8.  An intact NEDD8 pathway is required for Cullin-dependent ubiquitylation in mammalian cells.

Authors:  Michael Ohh; William Y Kim; Javid J Moslehi; Yuzhi Chen; Vincent Chau; Margaret A Read; William G Kaelin
Journal:  EMBO Rep       Date:  2002-01-29       Impact factor: 8.807

9.  Bromodeoxyuridine induces senescence in neural stem and progenitor cells.

Authors:  Heather H Ross; Lindsay H Levkoff; Gregory P Marshall; Maria Caldeira; Dennis A Steindler; Brent A Reynolds; Eric D Laywell
Journal:  Stem Cells       Date:  2008-09-18       Impact factor: 6.277

10.  Cell cycle activation and CNS injury.

Authors:  Bogdan A Stoica; Kimberly R Byrnes; Alan I Faden
Journal:  Neurotox Res       Date:  2009-04-21       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.